Home
Companies
Genmab
Clinical Trials

Clinical Trials Related to Genmab

Related studies linked through entity extraction aliases.

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

PRO1107 in Patients With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Status: RECRUITING
Phase: PHASE2

Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma

Status: TERMINATED
Phase: PHASE2

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Status: RECRUITING
Phase: PHASE1/PHASE2

A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Status: TERMINATED
Phase: PHASE1/PHASE2

Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2